SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001493152-23-031703
Filing Date
2023-09-06
Accepted
2023-09-05 18:02:45
Documents
13

Document Format Files

Seq Description Document Type Size
1 form424b3.htm 424B3 7002889
2 forms-4_001.jpg GRAPHIC 3079
3 forms-4_002.jpg GRAPHIC 3452
4 forms-4_003.jpg GRAPHIC 3078
5 forms-4_004.jpg GRAPHIC 70791
6 forms-4_005.jpg GRAPHIC 70631
7 forms-4_010.jpg GRAPHIC 1280
8 forms-4_006.jpg GRAPHIC 111274
9 forms-4_007.jpg GRAPHIC 55293
10 forms-4_008.jpg GRAPHIC 27337
11 forms-4_009.jpg GRAPHIC 63533
12 forms-4_016.jpg GRAPHIC 1658
13 annexb_001.jpg GRAPHIC 2530
  Complete submission text file 0001493152-23-031703.txt   7575340
Mailing Address HASATAT 8 ST. MODI'IN, L3 7178106
Business Address HASATAT 8 ST. MODI'IN, L3 7178106 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-271826 | Film No.: 231237209
SIC: 2834 Pharmaceutical Preparations